Difficulty: Medium
Average Score: 72%
Practice
Route of administration of 1,25-dihydroxyvitamin D3 (calcitriol) is:
Correct answer
D
Rationale
In pharmacology, understanding the route of administration for medications is crucial as it impacts drug absorption, distribution, and overall effectiveness. In the case of 1,25-dihydroxyvitamin D3 (calcitriol), the correct route of administration is oral (Option D).
The rationale for this is that calcitriol is a fat-soluble vitamin D hormone that is primarily administered orally for optimal absorption in the gastrointestinal tract. This route allows for gradual and controlled absorption, ensuring proper bioavailability and therapeutic effects.
The other options can be ruled out for various reasons:
A) Subcutaneous: Calcitriol is not typically administered subcutaneously as it may lead to unpredictable absorption rates and potential tissue irritation.
B) Intravenous: Intravenous administration of calcitriol is not common practice due to the risk of rapid and uncontrollable effects, as well as potential adverse reactions.
C) Intranasal: Administering calcitriol intranasally would not be appropriate as it is a hormone that requires systemic distribution through the bloodstream, which is best achieved via oral administration.
Educational context: Understanding the appropriate route of administration for medications is essential for safe and effective patient care. Healthcare providers must be knowledgeable about drug properties, patient factors, and best practices to ensure optimal outcomes. By selecting the correct route of administration, healthcare professionals can maximize therapeutic benefits while minimizing potential risks and adverse effects.
The rationale for this is that calcitriol is a fat-soluble vitamin D hormone that is primarily administered orally for optimal absorption in the gastrointestinal tract. This route allows for gradual and controlled absorption, ensuring proper bioavailability and therapeutic effects.
The other options can be ruled out for various reasons:
A) Subcutaneous: Calcitriol is not typically administered subcutaneously as it may lead to unpredictable absorption rates and potential tissue irritation.
B) Intravenous: Intravenous administration of calcitriol is not common practice due to the risk of rapid and uncontrollable effects, as well as potential adverse reactions.
C) Intranasal: Administering calcitriol intranasally would not be appropriate as it is a hormone that requires systemic distribution through the bloodstream, which is best achieved via oral administration.
Educational context: Understanding the appropriate route of administration for medications is essential for safe and effective patient care. Healthcare providers must be knowledgeable about drug properties, patient factors, and best practices to ensure optimal outcomes. By selecting the correct route of administration, healthcare professionals can maximize therapeutic benefits while minimizing potential risks and adverse effects.